Cyteir Therapeutics, Inc. Annual Return On Equity in % from 2020 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cyteir Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2022.
  • Cyteir Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2023 was -24.9 %, a 13.9% increase year-over-year.
  • Cyteir Therapeutics, Inc. annual Return On Equity for 2022 was -28.9 %, a 10.2% increase from 2021.
  • Cyteir Therapeutics, Inc. annual Return On Equity for 2021 was -32.1 %, a 163% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -28.9 +3.28 +10.2% Jan 1, 2022 Dec 31, 2022
2021 -32.1 -82.9 -163% Jan 1, 2021 Dec 31, 2021
2020 50.8 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.